Chordate Medical is one of the medtech companies participating at the Biostock Investor Meeting on March 16th. CEO Anders Weilandt will present the company at 11:00 a.m. and talk about the company’s focus in 2023 and beyond. After the presentation, he will answer questions in an interview. The presentation will be in English, and the interview will be held in Swedish.
Anders will, among other things, talk about the positive results from the recently completed migraine study, as well as the ongoing work to create proof-of-concept in the selected markets.